Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review.

about

Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review.

Item

http://www.wikidata.org/entity/Q48255019

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Concurrent ROS1 gene rearrange ...... report and literature review.

@en

Concurrent ROS1 gene rearrange ...... report and literature review.

@nl

type

Item

label

Concurrent ROS1 gene rearrange ...... report and literature review.

@en

Concurrent ROS1 gene rearrange ...... report and literature review.

@nl

prefLabel

Concurrent ROS1 gene rearrange ...... report and literature review.

@en

Concurrent ROS1 gene rearrange ...... report and literature review.

@nl

P1476

Concurrent ROS1 gene rearrange ...... report and literature review.

@en

P2093

Hua-Fei Chen

http://www.w3.org/2001/XMLSchema#string

Jian-Fa Shen

http://www.w3.org/2001/XMLSchema#string

Jian-Guo Wei

http://www.w3.org/2001/XMLSchema#string

Kai-Qi Du

http://www.w3.org/2001/XMLSchema#string

Li-Xin Wu

http://www.w3.org/2001/XMLSchema#string

Xiao-Feng Li

http://www.w3.org/2001/XMLSchema#string

Xue-Ping Lin

http://www.w3.org/2001/XMLSchema#string

You-Cai Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

ROS1 rearrangements define a unique molecular class of lung cancers.

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

Molecular Changes Associated with Acquired Resistance to Crizotinib in ROS1-Rearranged Non-Small Cell Lung Cancer.

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

RET, ROS1 and ALK fusions in lung cancer.

Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion.

Identifying and targeting ROS1 gene fusions in non-small cell lung cancer.

Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements

Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.

P304

159-163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1111/1759-7714.12518

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wen-Xian Wang

Chun-Wei Xu

P577

2017-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28971587

http://www.w3.org/2001/XMLSchema#string

P932

5754306

http://www.w3.org/2001/XMLSchema#string